Table 1.
Variable | Overall |
---|---|
Demographics | |
Age, years, n (%) | |
<65 | 51 (65) |
≥65 | 28 (35) |
Gender, n (%) | |
Male | 34 (43) |
Female | 45 (57) |
Race, n (%) | |
White | 73 (92) |
Non-White | 6 (8) |
Patient and operative characteristics | |
BMI, n (%) | |
Normal | 23 (29) |
Obese | 23 (29) |
Overweight | 33 (42) |
ASA class | |
2 | 11 (14) |
3 | 66 (84) |
4 | 2 (3) |
Albumin, g/dl, n (%) | |
<3.5 | 21 (27) |
≥3.5 | 58 (73) |
Cancer diagnosis, n (%) | 69 (87) |
Neoadjuvant therapy, n (%) | 26 (33) |
Type of surgery, n (%) | |
Gastrointestinal | 40 (51) |
Liver | 14 (18) |
Pancreas | 23 (29) |
Other | 2 (3) |
Operative approach, n (%) | |
Open | 47 (60) |
Robotic | 24 (30) |
Laparoscopic | 5 (6) |
Conversion to open | 3 (4) |
Postoperative characteristics | |
Drain on discharge, n (%) | 7 (9) |
Perioperative transfusion, n (%) | 6 (8) |
Postoperative complications, n (%) | 27 (34) |
Additional procedures, n (%) | 9 (11) |
Reoperation, n (%) | 2 (3) |
Length of stay >10 days, n (%) | 8 (10) |
Discharge to home, n (%) | 78 (99) |
Readmission ≤90 days, n (%) | 17 (22) |
Mortality 90 days, n (%) | 0 (0) |
ASA, American Society of Anesthesiologists; g/dl, grams/deciliter